- 专利标题： BUPROPION AS A MODULATOR OF DRUG ACTIVITY
-
申请号： US17473860申请日： 2021-09-13
-
公开(公告)号： US20210401831A1公开(公告)日： 2021-12-30
- 发明人: Herriot Tabuteau
- 申请人： ANTECIP BIOVENTURES II LLC
- 申请人地址： US NY NEW YORK
- 专利权人： ANTECIP BIOVENTURES II LLC
- 当前专利权人： ANTECIP BIOVENTURES II LLC
- 当前专利权人地址： US NY NEW YORK
- 主分类号： A61K31/485
- IPC分类号： A61K31/485 ; A61K31/137 ; A61K31/4748 ; A61K31/138 ; A61K9/00
摘要：
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
公开/授权文献
- US11590124B2 Bupropion as a modulator of drug activity 公开/授权日：2023-02-28
信息查询
IPC分类:
